Terms: = Head and neck cancer AND RSPO2, Q6UXX9, 340419, ENSG00000147655, MGC43342, MGC35555
5 results:
1. rspo2 silence inhibits tumorigenesis of nasopharyngeal carcinoma by ZNRF3/Hedgehog-Gli1 signal pathway.
Wang Z; Wang Y; Ma X; Dang C
Life Sci; 2021 Oct; 282():119817. PubMed ID: 34273374
[TBL] [Abstract] [Full Text] [Related]
2. Epithelial stem cell marker LGR6 expression identifies a low-risk subgroup in human papillomavirus positive oropharyngeal squamous cell carcinoma.
Jank BJ; Kadletz L; Dunkler D; Haas M; Schnoell J; Kenner L; Heiduschka G
Oral Oncol; 2020 Jun; 105():104657. PubMed ID: 32244172
[TBL] [Abstract] [Full Text] [Related]
3. LGR6 is a potential diagnostic and prognostic marker for esophageal squamous cell carcinoma.
Chai T; Shen Z; Zhang Z; Chen S; Gao L; Zhang P; Lin W; Kang M; Lin J
J Clin Lab Anal; 2020 Apr; 34(4):e23121. PubMed ID: 31917882
[TBL] [Abstract] [Full Text] [Related]
4. R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling.
Zhang L; Song Y; Ling Z; Li Y; Ren X; Yang J; Wang Z; Xia J; Zhang W; Cheng B
EBioMedicine; 2019 Jun; 44():275-288. PubMed ID: 31097406
[TBL] [Abstract] [Full Text] [Related]
5. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
[TBL] [Abstract] [Full Text] [Related]
